^
BIOMARKER:

FLT3-ITD mutation

i
Other names: FLT3, Fms Related Tyrosine Kinase 3, Receptor-Type Tyrosine-Protein Kinase FLT3, Stem Cell Tyrosine Kinase 1, Fms-Like Tyrosine Kinase 3, CD135, FLK-2, STK1, Growth Factor Receptor Tyrosine Kinase Type III, Fetal Liver Kinase 2
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
FLT3-ITD mutation
Acute Myelogenous Leukemia
TP-0184
Sensitive
:
D
SOHO 2022 - 1 week - (New D)
FLT3-ITD mutation
Acute Myelogenous Leukemia
midostaurin
Sensitive
:
A2
FLT3-ITD mutation
Acute Myelogenous Leukemia
gilteritinib
Sensitive
:
A2
FLT3-ITD mutation
Acute Myelogenous Leukemia
sorafenib
Sensitive
:
A2
FLT3-ITD mutation
Acute Myelogenous Leukemia
cytarabine
Resistant
:
B
FLT3-ITD mutation
Acute Myelogenous Leukemia
venetoclax + azacitidine
Sensitive
:
B
FLT3-ITD mutation
Acute Myelogenous Leukemia
venetoclax
Sensitive
:
C2
FLT3-ITD mutation
Acute Myelogenous Leukemia
ponatinib
Sensitive
:
C2
FLT3-ITD mutation
Acute Myelogenous Leukemia
quizartinib
Sensitive
:
C2
FLT3-ITD mutation
Acute Myelogenous Leukemia
TP-0903
Sensitive
:
C2
FLT3-ITD mutation
Acute Myelogenous Leukemia
PHI-101
Sensitive
:
C2
FLT3-ITD mutation
Acute Myelogenous Leukemia
pexidartinib
Sensitive
:
C2
FLT3-ITD mutation
Acute Myelogenous Leukemia
quizartinib + RAIN-32
Sensitive
:
C2
FLT3-ITD mutation
Acute Myelogenous Leukemia
venetoclax + quizartinib
Sensitive
:
C2
FLT3-ITD mutation
Acute Myelogenous Leukemia
HEC73543
Sensitive
:
C2
FLT3-ITD mutation
Acute Myelogenous Leukemia
quizartinib
Sensitive
:
C2
FLT3-ITD mutation
Acute Myelogenous Leukemia
ARO-002
Sensitive
:
C2
FLT3-ITD mutation
Acute Myelogenous Leukemia
gilteritinib + quizartinib + fingolimod
Sensitive
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3 inhibitor
Sensitive
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
cytarabine
Resistant
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
venetoclax + gilteritinib
Sensitive
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
gemtuzumab ozogamicin
Sensitive
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
selumetinib
Resistant
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
venetoclax + ruxolitinib
Sensitive
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
sorafenib + gilteritinib
Sensitive
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
FF-10101
Sensitive
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
DCAG
Sensitive
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
decitabine
Sensitive
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
DA
Sensitive
:
C4
FLT3-ITD mutation
Acute Myelogenous Leukemia
SGN-CD33A
Sensitive
:
D
FLT3-ITD mutation
Acute Myelogenous Leukemia
bortezomib + verteporfin
Sensitive
:
D
FLT3-ITD mutation
Acute Myelogenous Leukemia
bortezomib
Sensitive
:
D
FLT3-ITD mutation
Acute Myelogenous Leukemia
Max-40279
Sensitive
:
D